Has Jesse Ryan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $11,806 in general payments to Jesse Ryan, MD across 56 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jesse Ryan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jesse Ryan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jesse Ryan, MD

Otolaryngology · Liverpool, NYNPI 1285792143

Payments from drug & device makers

$11,806in general payments, 2019–2025

Across 56 payments — averaging $210.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Aerin Medical Inc.$5K
Intersect ENT, Inc.$4K
Ambu Inc.$1K
Inspire Medical Systems, Inc.$1K
Stryker$150
Optinose US, Inc.$142
plus $82 from 3 others

What the payments were for

Consulting fees$4,95042%
Travel & lodging$3,73432%
Food & beverage$3,12126%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Aerin Medical Inc.	17	$4,544
Intersect ENT, Inc.	19	$4,195
Ambu Inc.	1	$1,350
Inspire Medical Systems, Inc.	11	$1,343
Stryker	2	$150
Optinose US, Inc.	2	$142
Medtronic	2	$34
Hologic Sales And Service, LLC	1	$31
GSK	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VIVAER STYLUS$3,999
RHINAER STYLUS$3,999
SINUVA$3,723
Inspire$1,048
ENTELLUS - XPRESS ENT DILATION SYSTEM$125
Xhance$121
VivAer$118
RhinAer$118

How this compares

$11,806 in reported general payments places this provider in the 90th percentile of 701 otolaryngology providers in New York.

See all otolaryngology providers in New York →

Medicare billing

Part B allowed, 2024

$81,952

Medicare patients

174

Services billed

410

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	25	$347
Mupirocin	29	$209

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Liverpool

Robert KellmanSyracuse$2.5M
Anthony DelsignoreNew York$966K
Roheen RaithathaNew York$882K
Dennis KrausNew York$524K
Ashutosh KackerNew York$387K
Lawrence LustigNew York$383K
Brett MilesNew York$368K
Alfred Marc IloretaNew York$342K
Nora PerkinsAlbany$315K
Gavin SetzenAlbany$299K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →